info@alizaibfoundation.org  03111-444-(AZF)-293

Patient Treatment Cycle

At the Alizaib Foundation, we are committed to providing comprehensive care and support to patients living with thalassemia and hemophilia throughout their treatment journeys. Our patient treatment cycle encompasses the following stages:

Diagnosis and Assessment:

  • The journey begins with accurate diagnosis through specialized laboratory tests, including complete blood count (CBC), hemoglobin electrophoresis, clotting factor assays, and genetic testing.
  • Our dedicated healthcare professionals assess the severity and type of thalassemia or hemophilia to tailor treatment plans according to each patient's needs.

Treatment Planning and Education:

  • Based on the diagnosis and assessment, a personalized treatment plan is developed in consultation with the patient and their family.
  • We provide comprehensive education and counseling to empower patients and caregivers with knowledge about disease management, treatment options, and potential complications.

Factor Replacement Therapy and Transfusions:

  • For individuals with hemophilia, factor replacement therapy is the cornerstone of treatment, involving the infusion of clotting factor concentrates to prevent or manage bleeding episodes.
  • Patients with thalassemia may require regular blood transfusions to maintain adequate hemoglobin levels and alleviate symptoms of anemia.
  • Our specialized infusion center ensures the safe and effective administration of clotting factor products and blood products, tailored to each patient's needs.

Iron Chelation Therapy:

  • To prevent iron overload resulting from frequent transfusions in thalassemia patients, iron chelation therapy is employed using specialized medications.
  • Regular monitoring of iron levels and adjustment of chelation therapy help mitigate the risk of complications such as organ damage.

Prophylactic Treatment and Comprehensive Care:

  • Prophylactic treatment may be recommended for individuals with severe hemophilia or a history of frequent bleeding, aimed at preventing bleeding episodes and preserving joint health.
  • Our multidisciplinary team provides holistic care and support to address the psychosocial and emotional needs of patients and their families, enhancing quality of life and promoting resilience.

Management of Bleeding Episodes and Complications:

  • Despite prophylactic treatment, bleeding episodes may still occur in patients with hemophilia, necessitating prompt recognition and management.
  • Thalassemia and hemophilia-related complications, such as joint damage and iron overload, are monitored and managed through specialized interventions and rehabilitation services.

Long-Term Management, Follow-Up, and Research:

  • Thalassemia and hemophilia are chronic conditions requiring lifelong management and monitoring.
  • We establish structured follow-up schedules to track treatment efficacy, manage complications, and adapt treatment plans as needed to optimize patient outcomes.
  • Committed to advancing care, we actively participate in research initiatives and clinical trials to explore new treatments, gene therapies, and therapeutic approaches for thalassemia and hemophilia.
Back To Top